115 related articles for article (PubMed ID: 8198983)
1. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
Abdelmoumene N; Schlumberger M; Gardet P; Roche A; Travagli JP; Francese C; Parmentier C
Br J Cancer; 1994 Jun; 69(6):1141-4. PubMed ID: 8198983
[TBL] [Abstract][Full Text] [Related]
2. [Results of selective venous site-specific catheterization in occult C-cell carcinoma of the thyroid gland].
Cupisti K; Simon D; Dotzenrath C; Goretzki PE; Röher HD
Langenbecks Arch Chir; 1997; 382(6):295-301. PubMed ID: 9498199
[TBL] [Abstract][Full Text] [Related]
3. [Detection of residual lesions and metastases of medullary thyroid cancer].
Murat A
Ann Endocrinol (Paris); 1996; 57(1):27-32. PubMed ID: 8734286
[TBL] [Abstract][Full Text] [Related]
4. Biochemical results of reoperations for medullary thyroid carcinoma.
Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
[TBL] [Abstract][Full Text] [Related]
5. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
[TBL] [Abstract][Full Text] [Related]
6. Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma.
Machens A; Gimm O; Ukkat J; Sutter T; Dralle H
Langenbecks Arch Surg; 1999 Jun; 384(3):271-6. PubMed ID: 10437616
[TBL] [Abstract][Full Text] [Related]
7. Persistent hypercalcitoninemia in patients with medullary thyroid cancer: a therapeutic approach based on selective venous sampling for calcitonin.
Medina-Franco H; Herrera MF; López G; Tielve-Campillo M; Sierra M; Lozano-Salazar RR; González O
Rev Invest Clin; 2001; 53(3):212-7. PubMed ID: 11496707
[TBL] [Abstract][Full Text] [Related]
8. Reoperation for recurrent or persistent medullary thyroid cancer.
Moley JF; Wells SA; Dilley WG; Tisell LE
Surgery; 1993 Dec; 114(6):1090-5; discussion 1095-6. PubMed ID: 8256212
[TBL] [Abstract][Full Text] [Related]
9. Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization.
Frank-Raue K; Raue F; Buhr HJ; Baldauf G; Lorenz D; Ziegler R
Thyroid; 1992; 2(2):113-7. PubMed ID: 1525578
[TBL] [Abstract][Full Text] [Related]
10. Persistent hypercalcitoninemia in patients with medullary thyroid cancer.
Misso C; Calzolari F; Puxeddu E; Lucchini R; Monacelli M; Giammartino C; Sanguinetti A; d'Ajello M; Ragusa M; Avenia N
Tumori; 2009; 95(4):484-7. PubMed ID: 19856661
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
Mucha SA; Kunert-Radek J; Pomorski L
Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
13. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified?
Gimm O; Dralle H
Surgery; 1997 Dec; 122(6):1124-30; discussion 1130-1. PubMed ID: 9426428
[TBL] [Abstract][Full Text] [Related]
14. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination?
Machens A; Hauptmann S; Dralle H
J Clin Endocrinol Metab; 2008 Jun; 93(6):2234-8. PubMed ID: 18364379
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer.
Tung WS; Vesely TM; Moley JF
Surgery; 1995 Dec; 118(6):1024-9; discussion 1029-30. PubMed ID: 7491518
[TBL] [Abstract][Full Text] [Related]
17. Improved results of cervical reoperation for medullary thyroid carcinoma.
Moley JF; Dilley WG; DeBenedetti MK
Ann Surg; 1997 Jun; 225(6):734-40; discussion 740-3. PubMed ID: 9230814
[TBL] [Abstract][Full Text] [Related]
18. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
19. Markedly elevated serum calcitonin concentrations associated with initial presentation but not the recurrent presentation of medullary thyroid carcinoma.
Bodenner D; Nalley C; Chien C; Clarke B; Spring PM; Stack BC
Thyroid; 2010 Aug; 20(8):927-9. PubMed ID: 20677998
[No Abstract] [Full Text] [Related]
20. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
